{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:07:22Z","timestamp":1775250442372,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006939","name":"Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.clcc.2019.08.002","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T11:20:44Z","timestamp":1567596044000},"page":"257-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical Outcomes of Small Bowel Adenocarcinoma"],"prefix":"10.1016","volume":"18","author":[{"given":"Mehmet","family":"Akce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renjian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Zakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olatunji B.","family":"Alese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid L.","family":"Shaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusmita","family":"Behera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel F.","family":"El-Rayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2019.08.002_bib1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrclinonc.2013.132","article-title":"Small bowel adenocarcinomas\u2014existing evidence and evolving paradigms","volume":"10","author":"Raghav","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2019.08.002_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0038-1660482","article-title":"Small bowel adenocarcinoma","volume":"31","author":"Chen","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.clcc.2019.08.002_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjsurg.2009.05.037","article-title":"A\u00a0single-institution experience with 491 cases of small bowel adenocarcinoma","volume":"199","author":"Halfdanarson","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/j.clcc.2019.08.002_bib5","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2019.08.002_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1245\/s10434-011-2173-6","article-title":"A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease","volume":"19","author":"Overman","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/DCR.0000000000000562","article-title":"Treatment and survival of small-bowel adenocarcinoma in the united states: a comparison with colon cancer","volume":"59","author":"Young","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2019.08.002_bib8","first-page":"CD005202","article-title":"Adjuvant chemotherapy for small intestine adenocarcinoma","author":"Singhal","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clcc.2019.08.002_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/02841860903490051","article-title":"Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine","volume":"49","author":"Overman","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cncr.29840","article-title":"Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score\u2013matched analysis","volume":"122","author":"Ecker","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib11","first-page":"220","article-title":"Evaluation of prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma who underwent curative resection","volume":"16","author":"Aydin","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib12","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3892\/ol.2014.1919","article-title":"Small bowel adenocarcinoma\u2014terra incognita: a demand for cross-national pooling of data","volume":"7","author":"Schwameis","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clcc.2019.08.002_bib13","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdq038","article-title":"Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study","volume":"21","author":"Zaanan","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01. coc.0000214931.01062.01","article-title":"Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases","volume":"29","author":"Fishman","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cncr.20404","article-title":"Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients","volume":"101","author":"Dabaja","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9610(84)90036-9","article-title":"Adenocarcinoma of the small intestine","volume":"147","author":"Ouriel","year":"1984","journal-title":"Am J Surg"},{"key":"10.1016\/j.clcc.2019.08.002_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2407-11-205","article-title":"Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study","volume":"11","author":"Koo","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clon.2006.12.001","article-title":"Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency","volume":"19","author":"Czaykowski","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/CAD.0b013e328350dd0d","article-title":"A\u00a0phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma","volume":"23","author":"Xiang","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clcc.2019.08.002_bib20","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","article-title":"Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater","volume":"27","author":"Overman","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib21","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/cncr.30766","article-title":"North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma","volume":"123","author":"McWilliams","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/annonc\/mdx688","article-title":"Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer","volume":"29","author":"Overman","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2019.08.002_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/cncr.30445","article-title":"Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of Vater: a single-center, open-label, phase 2 study","volume":"123","author":"Gulhati","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib24","doi-asserted-by":"crossref","first-page":"e9672","DOI":"10.1097\/MD.0000000000009672","article-title":"Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma: case report and literature review","volume":"97","author":"Falcone","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.clcc.2019.08.002_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjc.6605898","article-title":"Cetuximab in small bowel adenocarcinoma: a new friend?","volume":"103","author":"Santini","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib26","first-page":"78","article-title":"Evaluation of bevacizumab in advanced small bowel adenocarcinoma","volume":"16","author":"Aydin","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2019.08.002_bib27","doi-asserted-by":"crossref","first-page":"277.e226","DOI":"10.1634\/theoncologist.2017-0568","article-title":"Phase II study of panitumumab in ras wild-type metastatic adenocarcinoma of small bowel or ampulla of Vater","volume":"23","author":"Gulhati","year":"2018","journal-title":"Oncologist"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002819302865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002819302865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:06:47Z","timestamp":1761520007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002819302865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1533002819302865"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2019.08.002","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Small Bowel Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2019.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}